Hospital Outpatient Drug Repercussion: Risks and Countermeasures

›› 2014, Vol. 9 ›› Issue (3): 143-150.doi:

• Research on Medical Care • 上一篇下一篇

Hospital Outpatient Drug Repercussion: Risks and Countermeasures

ZHAO Yang, WANG Shu-ling, TANG Xiao-mei, KONG Ling-yu

School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China

收稿日期:1900-01-01 修回日期:1900-01-01 出版日期:2014-09-20 发布日期:2014-09-20

Hospital Outpatient Drug Repercussion: Risks and Countermeasures

ZHAO Yang, WANG Shu-ling, TANG Xiao-mei, KONG Ling-yu

School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China

Received:1900-01-01 Revised:1900-01-01 Online:2014-09-20 Published:2014-09-20
Contact: KONG Ling-yu

摘要/Abstract

摘要： Objective To raise measures for reducing hospital outpatient drug repercussion in order to prevent the risks. Methods Typical case
analysis and statistical analysis were conducted. Results and Conclusion Drug repercussion phenomenon is caused by many factors,
such as imperfect hospital facilities, irrational prescriptions, patients’ weak awareness of rational drug use, etc. Therefore, it is
suggested some measures should be taken to reduce the risks of outpatient drug repercussion, for example, setting up related rules for
drug repercussion, regulating medical practice of doctors, strengthening the publicity, etc.

关键词: hospital pharmacy, outpatient drug repercussion, risk

Abstract: Objective To raise measures for reducing hospital outpatient drug repercussion in order to prevent the risks. Methods Typical case
analysis and statistical analysis were conducted. Results and Conclusion Drug repercussion phenomenon is caused by many factors,
such as imperfect hospital facilities, irrational prescriptions, patients’ weak awareness of rational drug use, etc. Therefore, it is
suggested some measures should be taken to reduce the risks of outpatient drug repercussion, for example, setting up related rules for
drug repercussion, regulating medical practice of doctors, strengthening the publicity, etc.

Key words: hospital pharmacy, outpatient drug repercussion, risk

ZHAO Yang;WANG Shu-ling;TANG Xiao-mei;KONG Ling-yu. Hospital Outpatient Drug Repercussion: Risks and Countermeasures[J]. , 2014, 9(3): 143-150.

[1]	Yang Luyao, Dong Jiangping, Yang Yue. Research of FDA Risk-Based Drug Inspection Program and Its Enlightenment[J]. 亚洲社会药学, 2021, 16(2): 114-119.
[2]	Yang Yu, Shi Yu, Hu Rongbo, Tian Lijuan. Research and Enlightenment of EU Drug Risk Management Plan[J]. 亚洲社会药学, 2021, 16(1): 23-30.
[3]	Zhang Zhan, Xue Aoming, Zhang Fang. Research on Risk Identification of Supply Chain Management in Pharmaceutical Wholesale Enterprises——Taking Enterprise A as an Example [J]. 亚洲社会药学, 2020, 15(4): 237-242.
[4]	Tang Ying, Chen Yuwen. Risk Control Strategy in the Research and Development of Pediatric Drugs[J]. 亚洲社会药学, 2019, 14(3): 110-118.
[5]	Lu Yiyang, Sun Lihua. Pharmacy Service in Private Hospitals: Problems and Countermeasures[J]. 亚洲社会药学, 2019, 14(3): 144-150.
[6]	Zhao Jianfeng, Zhang Wei, Yu Hai. Reflections on the Management of Preventing Interest Conflict among Pharmacopoeia Members[J]. 亚洲社会药学, 2019, 14(2): 39-44.
[7]	Jin Quanyuan, Lin Xiaohui, Dong Li. Research on Setting up Patent Risk Management System in Medical colleges and universities in China[J]. 亚洲社会药学, 2018, 13(1): 8-15.
[8]	Luo Lijun, Yang Yue. Research on Promoting Effectiveness of Supplier on-site Audit [J]. 亚洲社会药学, 2017, 12(4): 140-143.
[9]	Wei Fenfang, Zheng Yongxia, Yang Yue. Analysis of 13,472 Cases of Adverse Drug Reaction/Event of Ceftriaxone Sodium for Injection [J]. 亚洲社会药学, 2017, 12(1): 22-30.
[10]	Wei Fenfang, Zhang Zhongyi, Zheng Yongxia, Yang Yue. Analysis of 4,562 Cases of Adverse Drug Reaction/Event Caused by Cefoperazone Sodium and Sulbactam Sodium for Injection[J]. 亚洲社会药学, 2016, 11(4): 135-143.
[11]	. The Application of HACCP System in Drug Distribution[J]. 亚洲社会药学, 2016, 11(1): 37-41.
[12]	YANG Na;CHEN Yu-wen. Risk Reviews of Preclinical Pharmaceutical Studieson Traditional Chinese Medicine Injection[J]. , 2015, 10(3): 143-148.
[13]	LI Hui;HUANG Zhe. Risks and Risk Control Measures ofin vivo Genotoxicity Test in New Drug R&D[J]. , 2015, 10(3): 139-142.
[14]	YAN Quan;SHAO Rong. Analysis of the Controllability of Drug Risk Based on AHP[J]. , 2015, 10(2): 73-78.
[15]	ZHANG Hao;WU Zhi-ang. The Cost-Benefit Analysis of Government Supervisionof Post-Market Drug Risks[J]. , 2015, 10(2): 57-60.

亚洲社会药学

Hospital Outpatient Drug Repercussion: Risks and Countermeasures

Hospital Outpatient Drug Repercussion: Risks and Countermeasures

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价